RhumbLine Advisers
CLOV icon

RhumbLine Advisers’s Clover Health Investments CLOV Stock Holding History

RhumbLine Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
520,397
+39,538
+8% +$134K ﹤0.01% 1784
2026
Q1 		$846K Sell
480,859
-2,531
-0.5% -$5.49K ﹤0.01% 2283
2025
Q4 		$1.14M Sell
483,390
-87,398
-15% -$239K ﹤0.01% 2159
2025
Q3 		$1.75M Sell
570,788
-13,671
-2% -$39K ﹤0.01% 1991
2025
Q2 		$1.63M Buy
584,459
+577,374
+8,149% +$1.9M ﹤0.01% 1993
2025
Q1 		$25.4K Buy
7,085
+3,160
+81% +$12.7K ﹤0.01% 3703
2024
Q4 		$12.4K Buy
3,925
+324
+9% +$1.16K ﹤0.01% 3857
2024
Q3 		$10.2K Buy
+3,601
New +$8.24K ﹤0.01% 3888
2023
Q3 		– Sell
-17,242
Closed -$15.5K – 4319
2023
Q2 		$15.5K Sell
17,242
-462,191
-96% -$410K ﹤0.01% 3858
2023
Q1 		$405K Buy
479,433
+16,699
+4% +$18.3K ﹤0.01% 2513
2022
Q4 		$430K Buy
462,734
+11,668
+3% +$15.6K ﹤0.01% 2535
2022
Q3 		$767K Buy
451,066
+37,600
+9% +$98.5K ﹤0.01% 2286
2022
Q2 		$885K Buy
+413,466
New +$1.1M ﹤0.01% 2202

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RhumbLine Advisers's CLOV Position: Q2 2026 in Review

RhumbLine Advisers increased its Clover Health Investments (CLOV) stake by 8.2% in Q2 2026, buying an estimated $134K and bringing the position to 520,397 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1784.

RhumbLine Advisers first reported a position in CLOV in Q2 2022 and has held it in 13 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • RhumbLine Advisers held 520,397 shares of Clover Health Investments worth $2.73M as of Q2 2026.
  • RhumbLine Advisers bought 39,538 Clover Health Investments shares in Q2 2026, an estimated $134K.
  • Clover Health Investments made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1784 holding.
  • RhumbLine Advisers first reported a position in Clover Health Investments in Q2 2022 and has held it in 13 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.